Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort

References

• Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;14:631–7.
   Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492–509.
   PubMed Web of Science ®Google Scholar
• The Finnish Medical Society Duodecim. [Current care guidelines on rheumatoid arthritis], in Finnish. (www.kaypahoito.fi). Accessed 2 December 2016.
   Google Scholar
• Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568–73.
   PubMed Web of Science ®Google Scholar
• Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppänen O, et al. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Ann Rheum Dis 2013;72:851–7.
   PubMed Web of Science ®Google Scholar
• Kievit W, Fransen J, Oerlemans AJ, Kuper HH, Van Der Laar MA, De Rooij DJ, et al. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomized controlled trials and clinical practice. Ann Rheum Dis 2007;14:1473–8.
   Web of Science ®Google Scholar
• Verschueren P, Westhovens R. Optimal care for early RA patients: the challenge of translating scientific data into clinical practice. Rheumatology (Oxford) 2011;14:1194–200.
   Web of Science ®Google Scholar
• Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials. Arthritis Rheum 2006;54:3399–407.
   PubMed Web of Science ®Google Scholar
• Hmamouchi I, Combe B, Fautrel B, Rincheval N, Lukas C. Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis “ESPOIR” cohort. Joint Bone Spine 2014;81:409–15.
   PubMed Web of Science ®Google Scholar
• Albrecht K, Callhoff J, Edelmann E, Schett G, Schneider M, Zink A. Clinical remission in rheumatoid arthritis. Data from the early arthritis cohort study CAPEA. Z Rheumatolol 2016;75:90–6.
   PubMed Web of Science ®Google Scholar
• Makinen H, Kautiainen H, Hannonen P, Sokka T. Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria: a 5-year followup study. J Rheumatol 2005;32:796–800.
   PubMed Web of Science ®Google Scholar
• Ma MH, Scott IC, Kinglsley GH, Scott DL. Remission in early rheumatoid arthritis. J Rheumatol 2010;37:1444–53.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.
   PubMed Web of Science ®Google Scholar
• Sokka T, Haugeberg G, Asikainen J, Widding Hansen IJ, Kokko A, Rannio T, et al. Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics. Clin Exp Rheumatol 2013;31:409–14.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, Van’t Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
   PubMed Web of Science ®Google Scholar
• Harris JA, Bykert VP, Hitchon CA, Keystone EC, Thorne JC, Boire G, et al. Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian early arthritis cohort. J Rheumatol 2013;40:1823–30.
   PubMed Web of Science ®Google Scholar
• Hazlewood GS, Thorne JC, Pope JE, Lin D, Tin D, Boire G, et al. The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis. Ann Rheum Dis 2016;75:1003–8.
   PubMed Web of Science ®Google Scholar
• Steunebrink LM, Versteeg GA, Vonkeman HE, Ten Klooster PM, Kuper HH, Zijlstra TR, et al. Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry. Arthritis Res Ther 2016;18:60.
   PubMed Web of Science ®Google Scholar
• Graudal N, Hubeck-Graudal T, Faurschou M, Baslund B, Jürgens G. Combination therapy with and without tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis of randomized trials. Arthritis Care Res (Hoboken) 2015;67:1487–95.
   PubMed Web of Science ®Google Scholar
• Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK, et al. Questionnaires in standard monitoring of patients with rheumatoid arthritis group. Remission and rheumatoid arthritis. Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642–51.
   PubMed Web of Science ®Google Scholar
• Castrejón I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T. Prediction of remission in a French early arthritis cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein antibodies, or radiographic erosions. J Rheumatol 2016;43:1285–91.
   PubMed Web of Science ®Google Scholar
• Krams T, Ruyssen-Witrand A, Nigon D, Degboe Y, Tobon G, Fautrel B, et al. Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: the ESPOIR cohort. Joint Bone Spine 2016;83:511–15.
   PubMed Web of Science ®Google Scholar